Member Info for TRENCH123

Avocet, try and have a positive outlook on life, don't be miserable all the time. You must be money mad

Avocet, investors maybe happy just to wait for news

You have been saying the same thing since last July, maybe one day you will get it right !!

I will be staying here regardless, fascinated to see how the PYC story unfolds

What has happened has gone. Potential investors are looking to what will happen from now onwards. Obvious really. So your are confident in your prediction that the share price will not go above its current share price of 0.30 in the next 12 months ? A few see things very differently. Let's see how this works out, it will be interesting

'While historical data can offer insights into long-term trends and market volatility, it cannot predict how specific investments or the market as a whole will behave in the future. Market conditions are constantly changing due to a myriad of factors including economic shifts, political events, technological innovations, and investor sentiment'

Trout, no one (even your good self) is able to predict the future with any certainty. As AI correctly specifies :-

'While historical data can offer insights into long-term trends and market volatility, it cannot predict how specific investments or the market as a whole will behave in the future. Market conditions are constantly changing due to a myriad of factors including economic shifts, political events, technological innovations, and investor sentiment'

Hence, Laura can rightly put forward her thoughts of what will happen in the future just the same as you do. Potential investors need to do their own research and form their own judgment and not continually blame others if things do not work out for them

Trout, you have had a very fair platform to post your negativity for many months. So of course it is 'open', with opinions shared both good and bad

This is the best site for open discussion

Avocet, sorry to disappoint you but the company is clearly a going concern. The independent auditors report from the latest financial accounts issued on 29th September 2025 includes this comment :-

'Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue'

Delays in getting regulatory approval for the trial (which was outside the control of PYC) resulted in the trial starting later than anticipated

Why would you think it not encouraging that the CEO of a fast growing exciting private company sees the trial as his top priority for the year ahead ?

The numbers of patients are higher than previously reported and the trial which which was set to finish around the end of March is being extended for a further nine months. This indicates to me that this important trial is going very well

Your pessimism is legendary !!

Also interesting that the CEO indicated that the strategic priority that he would be most focused on over the next 12 months was the clinical trials in the UK with 100 cancer patients. PYC are a key partner in these trials. They must be be progressing well and are possibly being expanded due to encouraging data

Recent interview with CEO of Beyond Blood Diagnostics, partners of PYC in ongoing trials with NHS Foundation Trust in Blackpool

https://www.youtube.com/watch?v=dTKcH75g6rA

JIm Millen comments from last month :-

''We are excited for the next stage in Physiomics' growth...with a record level of contracted projects, a new biometrics service-line already generating revenue, and significant progress across our personalised medicine dosing software initiative''

Lots going on in the background with news due on several fronts. Interesting times ahead IMHO

Worry not. Same with lots of AIM companies, volume comes with news

PYC are a decent company. I have found their comments/statements made to be genuine

It would be very strange to issue share options to a key employee and then make it harder to achieve the share price goals by diluting soon thereafter

One week ago share options were awarded to Jesse Thissen as an incentive. This suggests to me that PYC funds are in better shape than some on here may suggest and that they have no plans for a placing in the near future.

Sterling, as you say money is highly over-rated. Health and happiness are far more important

Dr.Jesse Thissen has made a very encouraging start as Head of Biometrics

The potential for growing the division is huge and PYC know it, hence the options

This is well worth a read for anyone with an interest in PYC

For the size of the company, the progress over the last year has been quite remarkable. The building blocks are well and truly being put in place for 2026 and beyond IMHO.